Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Latin American wireless operator NII Holdings Inc. ( NIHD - Analyst Report ) provided a dismal outlook for fiscal 2013, slashing its revenue and OIBDA projections by a significant margin. The new guidance was on the back of delay in the launch of 3G technology, higher churn, weaker exchange rate and lower average revenue per user (ARPU).
NII Holdings expects revenue to be in the range of $5.7–$5.9 billion and adjusted OIBDA to stay in the band of $600–$650 million. Additionally, the company expects mid-single digit subscriber growth for the projected year along with $1 billion of capital expenditure.
NII Holdings plan to successfully roll out 3G network across the highly lucrative Brazilian market. However, it may not prove to be beneficial for the company as these Latin American markets are hugely dominated by America Movil S.A.B. de C.V. ( AMX - Analyst Report ) and Telefornica SA ( TEF - Analyst Report ) . Moreover, America Movil started deploying 4G LTE across these regions, which may further expand churn rate for NII Holdings going forward.
Furthermore, deployment of 3G networks requires huge cash which happens to be a major drawback for NII Holdings, thereby slowing down things further.
Moreover, NII Holdings is involved in the process of phasing out Motorola Solution’s ( MSI - Analyst Report ) Integrated digital enhanced technology (IDEN) and consequently integrating its new Push to Talk (PTT) technology, hence driving cost and delaying the 3G launch.
To make matters worse, Standard and Poor’s (S&P) lowered NII Holdings’ corporate credit rating by one notch to B- from the previous B rating status. The company’s debt now falls six tiers below the investment grade and is the second of its kind in the last six months after its rating was lowered in August following weak second-quarter 2012 results.
Thus, it is to be seen how long NII Holdings can face such sustained headwinds without merging with any major telecom carriers.
Currently, NII Holdings carries a Zacks Rank #4 (Sell).
Read the full Analyst Report on NIHD
Read the full Analyst Report on MSI
Read the full Analyst Report on TEF
Read the full Analyst Report on AMX